At the diagnostic level, these designed molecules are conjugated with radioactive tracers (such as a Ga-68, positron emitter), which attach to the cancer cells, marking them for precise localization through PSMA PET imaging, thus achieving visual tracking of the primary lesion and metastatic lesions (30, 31). The gene discussed is FOLH1; the disease is cancer.